ETI-395

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameETI-395
Drug Alias NameETI-526ETI-395
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsStress Disorders, Post-TraumaticPsychotic DisordersParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEpiomed
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEpiomed
Active IndicationsN/A
Inactive IndicationsStress Disorders, Post-TraumaticPsychotic DisordersParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A